PROTARA THERAPEUTIC INC (TARA) Stock Income Statement
NASDAQ:TARA • US74365U1079
Current stock price
5.22 USD
+0.01 (+0.19%)
Last:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 64.55M | 49.15M | 43.61M | 37.54M | 47.49M | |||
| Research and Development | 42.41M | 31.50M | 24.79M | 16.67M | 21.09M | |||
| Selling, General, and Administrative Expenses | 21.77M | 17.32M | 18.49M | 20.63M | 26.40M | |||
| Operating Income | -64.55M | -49.15M | -43.61M | -37.54M | -47.49M | |||
| Interest Income/Expense | 6.38M | 4.17M | 3.19M | 1.11M | 240.00K | |||
| Other Income/Expense | 730.00K | 387.00K | N/A | N/A | N/A | |||
| Non Recurring Items | N/A | N/A | N/A | -29.52M | N/A | |||
| Income Before Taxes | -57.44M | -44.60M | -40.42M | -65.95M | -47.25M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -57.44M | -44.60M | -40.42M | -65.95M | -47.25M | |||
| EBITDA | -64.19M | -48.82M | -43.27M | -37.29M | -47.37M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.34 | -2.17 | -3.57 | -5.86 | -4.21 | |||
| Non GAAP EPS | -1.32 | -2.41 | -3.57 | -3.99 | -4.21 | |||
| Statistics | ||||||||
All data in USD